Skip to content

Research in Action Awards 2025

  • Dorrit Walsh

Save the Date: Monday, October 20, 2025 , when our Research in Action Awards return this fall! We'll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV). And until July 1, get tickets at our special-early bird rate!

Read more

Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies

  • Dorrit Walsh

This publication discusses findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on, and the facilitators and barriers to potential long-acting therapies for Hepatitis C virus (HCV) cure currently being developed by the LONGEVITY consortium, funded by the global health agency Unitaid.

Read more

Inside the Fight: A Day in the Life of TAG’s TB Team

  • Dorrit Walsh

What does TAG's work look like in action? Here we step into a day in the life of our TB program co-directors, Mike Frick and Lindsay McKenna, to see how their advocacy for better TB research and policy — made possible by your support — are driving meaningful change to save lives and empower communities affected by TB.

Read more

TAGline November 2024

  • Dorrit Walsh

This year’s edition of TAGline takes stock of the state of the HIV, TB, and HCV pandemics worldwide, and advances bold visions for what a future without them must look like.

Read more

2024 TAG Update

  • Dorrit Walsh

As we approach the end of 2024, we want to share with you some of the remarkable progress we’ve made together, and you'll see some of our work in the 2024 TAG Update.

Read more
Back To Top